{
    "id": 9173,
    "title": "Danske Lægemiddelstandarder 2002.2, juli supplement",
    "documentTypeId": "60",
    "isSagsforlobPeriodValid": true,
    "shortName": "BEK nr 9403 af 17/06/2002",
    "documentHtml": "<div class=\"bjelke\">Den fulde tekst</div><DIV CLASS=PARA ID=\"INDHOLD\"> \r\n\r\n\r\n\r\n<FONT SIZE=5><P ALIGN=\"CENTER\">Danske L&aelig;gemiddelstandarder 2002.2,<BR>  \r\n\r\n juli supplement </P>  \r\n\r\n</FONT>  \r\n\r\n<P>&nbsp;</P>  \r\n\r\n<P>Efter indstilling fra Farmakop&eacute;n&aelig;vnet fasts&aelig;tter  \r\n\r\n L&aelig;gemiddelstyrelsen herved, at Supplementsbind 4.2. (Suppl. 4.2) til  \r\n\r\n den g&aelig;ldende 4. udgave af den Europ&aelig;iske Farmakop&eacute;  \r\n\r\n tr&aelig;der i kraft den 1. juli 2002.</P>  \r\n\r\n<P>Supplementet omfatter s&aring;vel rettelser og tilf&oslash;jelser til den  \r\n\r\n generelle del af Ph.Eur. 4th Ed., som en r&aelig;kke nye og reviderede  \r\n\r\n standarder for r&aring;varer og l&aelig;gemidler. Supplement 4.2 indeholder i  \r\n\r\n alt 18 nye og 82 reviderede/korrigerede standarder for r&aring;varer og  \r\n\r\n l&aelig;gemidler. Ph. Eur. 4th Ed. Supplement 4.2 indeholder desuden 7  \r\n\r\n reviderede/korrigerede tekster til bogens generelle afsnit. En  \r\n\r\n fuldst&aelig;nding opdatering af DLS sektion 2 og 3 vedr. fortegnelse over  \r\n\r\n standarder for r&aring;varer og l&aelig;gemidler kan ses p&aring;  \r\n\r\n L&aelig;gemiddelstyrelsens hjemmeside: www.laegemiddelstyrelsen.dk. Ph. Eur.  \r\n\r\n 4th Ed. Supplement 4.2 indeholder &eacute;n revideret generel monografi, for  \r\n\r\n<I>Vaccines for human use.</I> </P>  \r\n\r\n<P>Med Ph. Eur. 4.2 og DLS 2002.2, Juli supplement er &eacute;n  \r\n\r\n navne&aelig;ndirng introduceret, idet <I>Cefadroxil</I> skifter navn til  \r\n\r\n<I>Cefadroxil monohydrate.</P>  \r\n\r\n</I>  \r\n\r\n<P>DLS 2002.2, juli supplement indeholder desuden enkelte tilf&oslash;jelser  \r\n\r\n til <I>Fortegnelse over love</I>, <I>bekendtg&oslash;relser m.m.</I> </P>  \r\n\r\n<P>1 monografi er udg&aring;et med DLS 2002.2, Juli supplement. Det er  \r\n\r\n DLS-monografien <I>Fructose</I> <I>for</I> <I>injection</I>. I den  \r\n\r\n forbindelse udg&aring;r ogs&aring; analysemetoden (-1,6-glucaner, som kun har  \r\n\r\n v&aelig;ret anvendt i forbindelse med den p&aring;g&aelig;ldende monografi.  \r\n\r\n Der henvises i stedet til Ph. Eur. monografien <I>Fructose</I>.</P>  \r\n\r\n<P>Ikrafttr&aelig;den sker i henhold til L&aelig;gemiddellovens §§4 og 8.  \r\n\r\n Standarderne i den nedenfor angivne liste udg&oslash;r et supplement til og  \r\n\r\n en revision af fortegnelsen over standarder for henholdsvis r&aring;varer,  \r\n\r\n l&aelig;gemidler og l&aelig;gemiddelformer i 2002-udgaven af Danske  \r\n\r\n L&aelig;gemiddelstandarder med supplement april 2002. </P>  \r\n\r\n<P>Meddelelse om ikrafttr&aelig;den af Danske L&aelig;gemiddelstandarder  \r\n\r\n indf&oslash;res i Statstidende, jfr. Kongelig anordning nr. 742 af den 13.  \r\n\r\n november 1987.</P>  \r\n\r\n<P>Udover de i DLS 2002.2, Juli supplement angivne &aelig;ndringer henvises  \r\n\r\n til DLS 2002.</P>  \r\n\r\n<P>INDHOLDSFORTEGNELSE</P>  \r\n\r\n<P>Danske l&aelig;gemiddelstandarder 2002.2</P>  \r\n\r\n<P>&AElig;ndringer</P>  \r\n\r\n<P>Nyoptaget</P>  \r\n\r\n<P>Udg&aring;et</P>  \r\n\r\n<P>Titel&aelig;ndring</P>  \r\n\r\n<P>Nyoptaget - kumuleret liste</P>  \r\n\r\n<P>&AElig;ndret</P>  \r\n\r\n<P>Fortegnelse over love,bekendtg&oslash;relser m.m.</P>  \r\n\r\n<P>Analysemetoder</P>  \r\n\r\n<P>&nbsp;</P>  \r\n\r\n<FONT SIZE=5><P ALIGN=\"CENTER\">&AElig;ndringer</P>  \r\n\r\n</FONT>  \r\n\r\n<P ALIGN=\"CENTER\">Nyoptaget</P>  \r\n\r\n<P ALIGN=\"CENTER\"></P>  \r\n\r\n<P>F&oslash;lgende standarder er nyoptagede i Danske  \r\n\r\n L&aelig;gemiddelstandarder fra den 1. juli 2002, i forhold til DLS 2002.1,  \r\n\r\n april supplement. Alle standarder refererer til Ph. Eur. 4th Ed., Suppl.  \r\n\r\n 4.2.</P>  \r\n\r\n<I><FONT SIZE=2><P>R&aring;varer</P></I></FONT>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=552>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ammonium glycyrrhizate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ammoniumglycyrrhizat</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Black horehound</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tandb&aelig;gerurt</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Butcher's broom</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Musetorn rhizom</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Carteolol hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Carteololhydrochlorid</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Cinnamon tincture</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ceylonkanel tinktur</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Clindamycin hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Clindamycinhydrochlorid</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Coagulation factor XI, human</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Koagulationfaktor XI, human</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Enilconazole for veterinary use</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Enilconazol til veterin&aelig;r anvendelse</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Equisetum stem</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Padderok</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Mastic</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Mastiks</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Nadolol</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Nadolol</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Pygeum africanum bark</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Afrikansk blommebark</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Red poppy petals</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Kornvalmueblomst</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Rifabutin</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Rifabutin</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tramadol hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tramadolhydrochlorid</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tramazoline hydrochloride monohydrate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tramazolinhydrochloridmonohydrat</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tribenoside</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tribenosid</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<I><FONT SIZE=2><P>L&aelig;gemidler</P></I></FONT>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=651>  \r\n\r\n<TR><TD WIDTH=\"47%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Hepatitis A vaccine  (inactivated,  \r\n\r\n virosome)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"53%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Hepatitis A vaccine (inaktiveret, virosom)</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"47%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Iodinated [125I] human albumin injection</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"53%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ioderet [125I] humant albumin  \r\n\r\n injektionsv&aelig;ske</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<P ALIGN=\"CENTER\">Udg&aring;et</P>  \r\n\r\n<P ALIGN=\"CENTER\"></P>  \r\n\r\n<P>F&oslash;lgende standard er udg&aring;et af Danske  \r\n\r\n L&aelig;gemiddelstandarder fra den 1. juli 2002, i forhold til DLS 2002.</P>  \r\n\r\n<I><FONT SIZE=2><P>R&aring;varer</P></I></FONT>  \r\n\r\n<P ALIGN=\"LEFT\"><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=207>  \r\n\r\n<TR><TD VALIGN=\"TOP\" HEIGHT=31>  \r\n\r\n<FONT SIZE=2><P>Fructose for injectionDLS 2002</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n</P>  \r\n\r\n<P ALIGN=\"CENTER\">Titel&aelig;ndring</P>  \r\n\r\n<P ALIGN=\"CENTER\"></P>  \r\n\r\n<P>F&oslash;lgende standard har &aelig;ndret titel i Danske  \r\n\r\n L&aelig;gemiddelstandarder fra 1. juli 2002, i forhold til DLS 2002.</P>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=651>  \r\n\r\n<TR><TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tidligere titel</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>G&aelig;ldende titel</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<I><FONT SIZE=2><P>R&aring;varer</I></FONT></TD>  \r\n\r\n<TD WIDTH=\"54%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"46%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cefadroxil</FONT></TD>  \r\n\r\n<TD WIDTH=\"54%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cefadroxil monohydrate</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<P ALIGN=\"CENTER\">Nyoptaget - kumuleret liste</P>  \r\n\r\n<P ALIGN=\"CENTER\"></P>  \r\n\r\n<P>F&oslash;lgende standarder er optagede i Danske L&aelig;gemiddelstandarder  \r\n\r\n fra den 1. juli 2002, i forhold til DLS 2002. </P>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=651>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ammonium glycyrrhizate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ammoniumglycyrrhizat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Articaine hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Articainhydrochlorid</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Black horehound</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tandb&aelig;gerurt</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Butcher's broom</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Musetorn rhizom</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Carteolol hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Carteololhydrochlorid</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Carvedilol</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Carvedilol</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Cinnamon tincture</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ceylonkanel tinktur</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Clary sage oil</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Muskatellersalvieolie</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Coagulation factor XI, human</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Koagulationfaktor XI, human</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Enilconazole for veterinary use</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Enilconazol til veterin&aelig;r anvendelse</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Equisetum stem</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Padderok</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ioxaglic acid</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ioxaglicinsyre</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ipecacuanha liquid extract</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ipecacuanha flydende ekstrakt</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Josamycin</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Josamycin</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Josamycin propionate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Josamycinpropionat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Juniper oil</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Eneb&aelig;rolie</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Macrogol 20 glycerol monostearate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Macrogol 20 glycerolmonostearat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Mastic</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Mastiks</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Mint oil, partly dementholised</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Mynteolie, delvist dementholiseret</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Nadolol</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Nadolol</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Palmitic acid</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Palmitinsyre</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Phytosterol</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Phytosterol</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Pipemidic acid trihydrate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Pipemidinsyretrihydrat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Potassium hydrogen tartrate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Kaliumhydrogentartrat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Potassium perchlorate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Kaliumperchlorat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Potassium sodium tartrate tetrahydrate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Kaliumnatriumtartrattetrahydrat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Pygeum africanum bark</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Afrikansk blommebark</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Red poppy petals</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Kornvalmueblomst</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Rifabutin</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Rifabutin</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Rosemary oil</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Rosmarinolie         </FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Sage tincture</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Salvietinktur</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Sorbitan sesquioleate</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sorbitansesquioleat</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tea tree oil</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tetr&aelig;olie</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Thioridazine</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Thioridazin</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tolfenamic acid</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tolfenamsyre</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tramadol hydrochloride</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tramadolhydrochlorid</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Tribenoside</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tribenosid</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=651>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><FONT SIZE=2><P>L&aelig;gemidler</I></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Canine adenovirus vaccine (live)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Adenovirus vaccine til hunde (levende)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Diphtheria, tetanus and pertussis (acellular, component)  \r\n\r\n vaccine (adsorbed)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Difteri-tetanus-kighoste (acellul&aelig;r, komponent) vaccine  \r\n\r\n (adsorberet)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Diphtheria, tetanus, pertussis (acellular, component) and  \r\n\r\n haemophilus type b conjugate vaccine (adsorbed)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Difteri-tetanus-kighoste (acellul&aelig;r, komponent) og  \r\n\r\n haemophilus influenza type b konjugeret vaccine (adsorberet)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Diphtheria, tetanus, pertussis (acellular, component) and  \r\n\r\n hepatitis B (rDNA) vaccine (adsorbed)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Difteri-tetanus-kighoste (acellul&aelig;r, komponent) og  \r\n\r\n hepatitis B (rDNA) vaccine (adsorberet)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1. </B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Diphtheria, tetanus, pertussis (acellular, component) and  \r\n\r\n poliomyelitis (inactivated) vaccine (adsorbed)</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Difteri-tetanus-kighoste (acellul&aelig;r, komponent) og  \r\n\r\n polio (inaktiveret) vaccine (adsorberet)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.1.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Hepatitis A vaccine  (inactivated, virosome)  \r\n\r\n</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Hepatitis A vaccine (inaktiveret, virosom)</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"33%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Iodinated [125I] human albumin injection</B></FONT></TD>  \r\n\r\n<TD WIDTH=\"37%\" VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ioderet [125I] humant albumin injektionsv&aelig;ske  \r\n\r\n</FONT></TD>  \r\n\r\n<TD WIDTH=\"30%\" VALIGN=\"TOP\">  \r\n\r\n<B><FONT SIZE=2><P>Ph. Eur. 4th Ed. Suppl. 4.2.</B></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<P>&AElig;ndret</P>  \r\n\r\n<P>F&oslash;lgende standarder er &aelig;ndret i Danske  \r\n\r\n L&aelig;gemiddelstandarder fra den 1. juli 2002. Alle standarder refererer  \r\n\r\n til Ph. Eur. 4th Ed., Suppl. 4.2.</P>  \r\n\r\n<I><P>R&aring;varer</P>  \r\n\r\n</I>  \r\n\r\n<FONT SIZE=2></FONT>  \r\n\r\n<P ALIGN=\"LEFT\"><TABLE BORDER CELLSPACING=1 CELLPADDING=4 WIDTH=368>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Acebutolol hydrochloride  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Alfacalcidol  \r\n\r\n           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Amlodipine besilate  \r\n\r\n                 </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ammonium bromide  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Angelica root  \r\n\r\n           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Butyl parahydroxybenzoate  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Carbomers  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Carmellose calcium  \r\n\r\n                 </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cefadroxil monohydrate  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cefazolin  sodium  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cefoxitin sodium  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ceftazidime  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cellulose, microcrystalline  \r\n\r\n                         </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cellulose, powdered  \r\n\r\n                 </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cetyl palmitate  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cholesterol  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cinchona bark  \r\n\r\n           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Clindamycin hydrochloride  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Crotamiton  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Cyanocobalamin  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Dexamethasone  \r\n\r\n           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Erythromycin  \r\n\r\n           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Erythromycin stearate  \r\n\r\n                   </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ethyl parahydroxybenzoate  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Etoposide  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Framycetin sulphate  \r\n\r\n                 </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Glyceryl trinitrate solution  \r\n\r\n                           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ibuprofen  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Insulin, human  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Isomalt  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Ivermectin  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Lobeline hydrochloride  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Lovage root  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Mebendazole  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Methyl parahydroxybenzoate  \r\n\r\n                         </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Mexiletine hydrochloride  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Neomycin sulphate  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Nitrogen  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Norethisterone acetate  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Oxytocin</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Oxytocin bulk solution  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Pethidine hydrochloride  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Phenylbutazone  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Potassium bromide  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Potassium clavulanate  \r\n\r\n                   </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Povidone  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Povidone, iodinated  \r\n\r\n                 </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Propyl parahydroxybenzoate  \r\n\r\n                         </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Riboflavine  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sodium bromide  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sodium sulphate, anhydrous</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sodium sulphate decahydrate  \r\n\r\n                         </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sorbitol  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Sotalol hydrochloride  \r\n\r\n                   </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Testosterone propionate  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Thiamine hydrochloride  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Thiamine nitrate  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tiapride hydrochloride  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tramazoline hydrochloride  \r\n\r\n                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Trolamine  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Vitamin A</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Vitamin A concentrate (oily form), synthetic  \r\n\r\n                                          </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Vitamin A concentrate (powder form), synthetic  \r\n\r\n                                            </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Vitamin A concentrate (solubilisate/emulsion), synthetic  \r\n\r\n                                                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Water for injections  \r\n\r\n                   </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Water, highly purified  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Water, purified  \r\n\r\n             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Xylitol  \r\n\r\n</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2>  \r\n\r\n<I><P>L&aelig;gemidler</I></FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Albumin solution, human  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Coagulation factor IX, human  \r\n\r\n                           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Coagulation factor VIII, human  \r\n\r\n                             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Diphteria and tetanus vaccine  (adsorbed)  \r\n\r\n                                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Diphtheria and tetanus vaccine (adsorbed) for adults and  \r\n\r\n adolescents</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Diphtheria, tetanus and pertussis vaccine  \r\n\r\n (adsorbed)</FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Diphtheria vaccine (adsorbed)  \r\n\r\n                           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Diphteria vaccine (adsorbed) for  adults and adolescents  \r\n\r\n                                                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Human anti-D immunoglobulin for  intravenous administration  \r\n\r\n                                                       </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Pertussis vaccine (adsorbed)  \r\n\r\n                           </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Pertussis vaccine  \r\n\r\n               </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Tetanus vaccine (adsorbed)  \r\n\r\n                         </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Typhoid polysaccharide vaccine  \r\n\r\n                             </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">  \r\n\r\n<FONT SIZE=2><P>Vaccines for human use  \r\n\r\n                     </FONT></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n</P>  \r\n\r\n<FONT SIZE=4><P ALIGN=\"CENTER\">Fortegnelse over love,bekendtg&oslash;relser  \r\n\r\n m.m.</P>  \r\n\r\n</FONT>  \r\n\r\n<P>Tilf&oslash;jelse:</P>  \r\n\r\n<P ALIGN=\"CENTER\">Bekendtg&oslash;relser</P>  \r\n\r\n<P>L&aelig;gemiddelstyrelsens bekendtg&oslash;relse <U>BEK nr 7 af  \r\n\r\n 08/01/2002</U> om m&aelig;rkning m.m. af l&aelig;gemidler</P>  \r\n\r\n<P>L&aelig;gemiddelstyrelsens bekendtg&oslash;relse<U> BEK nr 35 af  \r\n\r\n 21/01/2002 </U>om &aelig;ndring af bekendtg&oslash;relse om humant blod og  \r\n\r\n blodprodukter til l&aelig;gemiddelform&aring;l</P>  \r\n\r\n<P>Indenrigs- og Sundehedsministeriets <U>BEK nr 105 af 27/02/2002 </U>om  \r\n\r\n medicinsk udstyr</P>  \r\n\r\n<P>Indsat med DLS 2002.1, April supplement: </P>  \r\n\r\n<P>L&aelig;gemiddelstyrelsens bekendtg&oslash;relse nr. 837 af 20. september  \r\n\r\n 2001 om dosisdispensering af l&aelig;gemidler.</P>  \r\n\r\n<FONT SIZE=4><P ALIGN=\"CENTER\">Analysemetoder</P>  \r\n\r\n</FONT>  \r\n\r\n<P>Test for (-1,6-glucans udg&aring;r med DLS 2002.2, juli supplement.</P>  \r\n\r\n<FONT SIZE=5><P ALIGN=\"CENTER\"></P></FONT>  \r\n\r\n<DIV CLASS=GIVET ID=\"GIVET\">  \r\n\r\n<FONT SIZE=\"3\">  \r\n\r\n<P CLASS=GIVET ALIGN=\"CENTER\"><I>Lægemiddelstyrelsen, den 17. juni  \r\n\r\n 2002</I></P>  \r\n\r\n<P CLASS=SIGN1 ALIGN=\"CENTER\">Jytte Lyngvig</P>  \r\n\r\n<P CLASS=SIGN2 ALIGN=\"RIGHT\">/Finn H. Clemmensen</P>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"GIVET\" -->  \r\n\r\n</DIV>",
    "isHistorical": true,
    "editorialNotes": [],
    "alternativeMedia": [],
    "ressort": "Indenrigs- og Sundhedsministeriet",
    "popularTitle": "DLS 2002.2, Juli",
    "isReprint": false,
    "geografiskDaekningId": 0,
    "retsinfoKlassifikationId": 10,
    "caseHistoryReferenceGroup": [],
    "metadata": [
        {
            "displayName": "Offentliggørelsesdato",
            "displayValue": "27/08/2002"
        },
        {
            "displayName": "Accession",
            "displayValue": "B20020940305"
        },
        {
            "displayName": "Entydig dokumentidentifikation",
            "displayValue": "AI000727"
        },
        {
            "displayName": "Dato for førstegangsindlæggelse",
            "displayValue": "27/08/2002"
        },
        {
            "displayName": "Dato for indlæggelse",
            "displayValue": "13/02/2006"
        },
        {
            "displayName": "Dokumenttype",
            "displayValue": "Bekendtgørelse"
        },
        {
            "displayName": "Dokumentets rangering",
            "displayValue": "B "
        },
        {
            "displayName": "Forskriftens nummer",
            "displayValue": "9403"
        },
        {
            "displayName": "År for udstedelse",
            "displayValue": "2002"
        },
        {
            "displayName": "Dato for underskrift",
            "displayValue": "17/06/2002"
        },
        {
            "displayName": "Offentliggjort i (publiceringsmedie)",
            "displayValue": "Retsinformation"
        },
        {
            "displayName": "Administrerende myndighed",
            "displayValue": "Lægemiddelstyrelsen"
        },
        {
            "displayName": "Ressortministeriets journalnummer",
            "displayValue": "Indenrigs- og Sundhedsministeriet, j.nr. 0112-68"
        },
        {
            "displayName": "Stikord",
            "displayValue": "Kvalitet, Lægemidler, Standarder"
        }
    ],
    "pdfLink": {
        "isPdfAvailable": false
    },
    "documentFobTagGroup": [],
    "hasFobTags": false
}